Fund
| Item | Value |
|---|---|
| Ticker (pseudo) | FINH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | IndMom factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
Loading the page
| Item | Value |
|---|---|
| Ticker (pseudo) | FINH |
| CUSIP | Not applicable (hypothetical model portfolio) |
| Listing exchange | Not listed (hypothetical) |
| Underlying model | IndMom factor (Healthcare only) |
| Placeholder expense ratio | 0.45% |
| Placeholder inception date |
| 2020-11-05 |
| Number of holdings (long leg) | 91 |
| Weighting | Cap-weighted |
| Rebalance frequency | Monthly |
| Holdings as of | November 2026 |
| # | Ticker | Company | Sector | Weight | Market Value | CUSIP |
|---|---|---|---|---|---|---|
| 1 | PFE | PFIZER INC | Healthcare | 18.24% | $18,238,356 | HYP-PFE |
| 2 | VRTX | VERTEX PHARMACEUTICALS INC | Healthcare | 15.27% | $15,269,174 | HYP-VRTX |
| 3 | REGN | REGENERON PHARMACEUTICALS INC | Healthcare | 10.92% | $10,921,095 | HYP-REGN |
| 4 | TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | Healthcare | 5.65% | $5,652,857 | HYP-TEVA |
| 5 | ONC | BEONE MEDICINES LTD | Healthcare | 5.27% | $5,271,856 | HYP-ONC |
| 6 | RPRX | ROYALTY PHARMA PLC | Healthcare | 4.39% | $4,390,876 | HYP-RPRX |
| 7 | RVMD | REVOLUTION MEDICINES INC | Healthcare | 4.23% | $4,233,450 | HYP-RVMD |
| 8 | ZTS | ZOETIS INC | Healthcare | 3.74% | $3,741,194 | HYP-ZTS |
| 9 | ROIV | ROIVANT SCIENCES LTD | Healthcare | 3.22% | $3,215,909 | HYP-ROIV |
| 10 | UTHR | UNITED THERAPEUTICS CORP | Healthcare | 2.80% | $2,804,486 | HYP-UTHR |
| 11 | VTRS | VIATRIS INC | Healthcare | 2.63% | $2,630,112 | HYP-VTRS |
| 12 | SMMT | SUMMIT THERAPEUTICS INC | Healthcare | 1.34% | $1,338,120 | HYP-SMMT |
| 13 | TECH | BIO-TECHNE CORP | Healthcare | 1.27% | $1,269,984 | HYP-TECH |
| 14 | RGEN | REPLIGEN CORP | Healthcare | 1.18% | $1,181,426 | HYP-RGEN |
| 15 | PCVX | VAXCYTE INC | Healthcare | 1.14% | $1,136,565 | HYP-PCVX |
| 16 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 1.08% | $1,084,722 | HYP-SYRE |
| 17 | TGTX | TG THERAPEUTICS INC | Healthcare | 1.08% | $1,083,035 | HYP-TGTX |
| 18 | PRAX | PRAXIS PRECISION MEDICINES INC | Healthcare | 1.01% | $1,007,496 | HYP-PRAX |
| 19 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 0.97% | $973,479 | HYP-PTGX |
| 20 | RYTM | RHYTHM PHARMACEUTICALS INC | Healthcare | 0.85% | $845,365 | HYP-RYTM |
| 21 | TWST | TWIST BIOSCIENCE CORP | Healthcare | 0.79% | $794,943 | HYP-TWST |
| 22 | ORKA | ORUKA THERAPEUTICS INC | Healthcare | 0.79% | $790,315 | HYP-ORKA |
| 23 | PTCT | PTC THERAPEUTICS INC | Healthcare | 0.59% | $587,506 | HYP-PTCT |
| 24 | SRRK | SCHOLAR ROCK HOLDING CORP | Healthcare | 0.58% | $584,431 | HYP-SRRK |
| 25 | TVTX | TRAVERE THERAPEUTICS INC | Healthcare | 0.55% | $549,326 | HYP-TVTX |
| 26 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 0.47% | $467,372 | HYP-TNGX |
| 27 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 0.45% | $447,194 | HYP-XENE |
| 28 | RLAY | RELAY THERAPEUTICS INC | Healthcare | 0.44% | $443,387 | HYP-RLAY |
| 29 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 0.42% | $420,768 | HYP-TARS |
| 30 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 0.39% | $390,357 | HYP-VKTX |
| 31 | PBLS | PARABILIS MEDICINES INC | Healthcare | 0.38% | $379,647 | HYP-PBLS |
| 32 | XERS | XERIS BIOPHARMA HOLDINGS INC | Healthcare | 0.34% | $337,626 | HYP-XERS |
| 33 | VCEL | VERICEL CORP | Healthcare | 0.33% | $325,207 | HYP-VCEL |
| 34 | XNCR | XENCOR INC | Healthcare | 0.32% | $317,571 | HYP-XNCR |
| 35 | RCUS | ARCUS BIOSCIENCES INC | Healthcare | 0.28% | $283,986 | HYP-RCUS |
| 36 | SDGR | SCHRODINGER INC | Healthcare | 0.26% | $257,060 | HYP-SDGR |
| 37 | PRGO | PERRIGO CO PLC | Healthcare | 0.25% | $249,258 | HYP-PRGO |
| 38 | PBH | PRESTIGE CONSUMER HEALTHCARE INC | Healthcare | 0.24% | $238,403 | HYP-PBH |
| 39 | SUPN1 | SUPERNUS PHARMACEUTICALS INC | Healthcare | 0.23% | $234,496 | HYP-SUPN1 |
| 40 | VERA | VERA THERAPEUTICS INC | Healthcare | 0.23% | $233,031 | HYP-VERA |
| 41 | REPL | REPLIMUNE GROUP INC | Healthcare | 0.23% | $231,266 | HYP-REPL |
| 42 | VIR | VIR BIOTECHNOLOGY INC | Healthcare | 0.23% | $230,390 | HYP-VIR |
| 43 | TRAX | FIRST TRACKS BIOTHERAPEUTICS INC | Healthcare | 0.23% | $227,115 | HYP-TRAX |
| 44 | SEPN | SEPTERNA INC | Healthcare | 0.22% | $220,911 | HYP-SEPN |
| 45 | TRVI | TREVI THERAPEUTICS INC | Healthcare | 0.22% | $215,506 | HYP-TRVI |
| 46 | TRLV | TRULIEVE CANNABIS CORP | Healthcare | 0.21% | $211,155 | HYP-TRLV |
| 47 | ZBIO | ZENAS BIOPHARMA INC | Healthcare | 0.21% | $208,048 | HYP-ZBIO |
| 48 | ZYME | ZYMEWORKS INC | Healthcare | 0.20% | $202,798 | HYP-ZYME |
| 49 | QURE | UNIQURE NV | Healthcare | 0.19% | $191,732 | HYP-QURE |
| 50 | SRPT | SAREPTA THERAPEUTICS INC | Healthcare | 0.19% | $190,545 | HYP-SRPT |
| 51 | STOK | STOKE THERAPEUTICS INC | Healthcare | 0.19% | $190,190 | HYP-STOK |
| 52 | RARE | ULTRAGENYX PHARMACEUTICAL INC | Healthcare | 0.18% | $184,052 | HYP-RARE |
| 53 | SLS | SELLAS LIFE SCIENCES GROUP INC | Healthcare | 0.18% | $179,979 | HYP-SLS |
| 54 | RAPP | RAPPORT THERAPEUTICS INC | Healthcare | 0.17% | $170,079 | HYP-RAPP |
| 55 | PCRX | PACIRA BIOSCIENCES INC | Healthcare | 0.16% | $162,254 | HYP-PCRX |
| 56 | PAHC | PHIBRO ANIMAL HEALTH CORP | Healthcare | 0.16% | $159,790 | HYP-PAHC |
| 57 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 0.15% | $151,543 | HYP-TYRA |
| 58 | OMER | OMEROS CORP | Healthcare | 0.14% | $144,540 | HYP-OMER |
| 59 | URGN | UROGEN PHARMA LTD | Healthcare | 0.14% | $143,663 | HYP-URGN |
| 60 | VOR | VOR BIOPHARMA INC | Healthcare | 0.13% | $131,732 | HYP-VOR |
| 61 | SPTX | SEAPORT THERAPEUTICS INC | Healthcare | 0.12% | $119,601 | HYP-SPTX |
| 62 | VSTM | VERASTEM INC | Healthcare | 0.12% | $118,047 | HYP-VSTM |
| 63 | ORIC | ORIC PHARMACEUTICALS INC | Healthcare | 0.10% | $97,781 | HYP-ORIC |
| 64 | RIGL | RIGEL PHARMACEUTICALS INC | Healthcare | 0.10% | $95,483 | HYP-RIGL |
| 65 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 0.10% | $95,328 | HYP-SNDX |
| 66 | SLDB | SOLID BIOSCIENCES INC | Healthcare | 0.09% | $86,715 | HYP-SLDB |
| 67 | QDEL | QUIDELORTHO CORP | Healthcare | 0.08% | $80,877 | HYP-QDEL |
| 68 | QUIT | ACHIEVE LIFE SCIENCES INC | Healthcare | 0.08% | $76,815 | HYP-QUIT |
| 69 | SGMT | SAGIMET BIOSCIENCES INC | Healthcare | 0.08% | $75,405 | HYP-SGMT |
| 70 | ZVRA | ZEVRA THERAPEUTICS INC | Healthcare | 0.07% | $73,707 | HYP-ZVRA |
| 71 | OLMA | OLEMA PHARMACEUTICALS INC | Healthcare | 0.07% | $73,119 | HYP-OLMA |
| 72 | SRZN | SURROZEN INC | Healthcare | 0.07% | $67,004 | HYP-SRZN |
| 73 | RGNX | REGENXBIO INC | Healthcare | 0.06% | $58,935 | HYP-RGNX |
| 74 | TKNO | ALPHA TEKNOVA INC | Healthcare | 0.06% | $57,914 | HYP-TKNO |
| 75 | PHAT | PHATHOM PHARMACEUTICALS INC | Healthcare | 0.06% | $56,204 | HYP-PHAT |
| 76 | PRTA | PROTHENA CORP PUBLIC LTD CO | Healthcare | 0.05% | $46,904 | HYP-PRTA |
| 77 | TECX | TECTONIC THERAPEUTIC INC | Healthcare | 0.05% | $46,582 | HYP-TECX |
| 78 | PBYI | PUMA BIOTECHNOLOGY INC | Healthcare | 0.05% | $46,360 | HYP-PBYI |
| 79 | PEPG | PEPGEN INC | Healthcare | 0.04% | $38,746 | HYP-PEPG |
| 80 | SCTX | SCRIBE THERAPEUTICS INC | Healthcare | 0.04% | $35,694 | HYP-SCTX |
| 81 | TTRX | TURN THERAPEUTICS INC | Healthcare | 0.03% | $34,373 | HYP-TTRX |
| 82 | QTTB | Q32 BIO INC | Healthcare | 0.03% | $29,290 | HYP-QTTB |
| 83 | TRDA | ENTRADA THERAPEUTICS INC | Healthcare | 0.02% | $22,464 | HYP-TRDA |
| 84 | RNAC | CARTESIAN THERAPEUTICS INC | Healthcare | 0.02% | $21,510 | HYP-RNAC |
| 85 | STRO | SUTRO BIOPHARMA INC | Healthcare | 0.02% | $17,647 | HYP-STRO |
| 86 | RNA | ATRIUM THERAPEUTICS INC | Healthcare | 0.01% | $14,240 | HYP-RNA |
| 87 | SPRB | SPRUCE BIOSCIENCES INC | Healthcare | 0.01% | $13,685 | HYP-SPRB |
| 88 | RLYB | RALLYBIO CORP | Healthcare | 0.01% | $9,356 | HYP-RLYB |
| 89 | VTVT | VTV THERAPEUTICS INC | Healthcare | 0.01% | $9,212 | HYP-VTVT |
| 90 | XLO | XILIO THERAPEUTICS INC | Healthcare | 0.01% | $6,460 | HYP-XLO |
| 91 | YARW | YARROW BIOSCIENCE INC | Healthcare | 0.01% | $5,816 | HYP-YARW |
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.